The medical school will welcome Daniel Lingwood, PhD, in February as the featured speaker for Seminars in Investigative Medicine.
Dr. Lingwood’s presentation – “Immunologically simplified pathways for eliciting broad protection against influenza virus” – is scheduled for noon to 1 p.m. on Wednesday, February 19, 2025, in TBL 1 at the W.E. Upjohn M.D. Campus in downtown Kalamazoo. A pizza lunch from Erbelli’s will be provided for attendees.
The event is free and MEDU and CE credit is available. If you plan to attend, please register here. Individuals who RSVP will be admitted before those without a reservation.
Dr. Lingwood is an associate professor of Medicine at the Ragon Institute of MGH, MIT and Harvard University. Dr. Lingwood received his PhD in Cell Biology from Max Planck Institute for Molecular Cell Biology and Genetics in Dresden, Germany. He did postdoctoral work in Cell Biology and Vaccinology at Max Planck Institute for Molecular Cell Biology and the Vaccine Research Center (VRC) at the National Institutes of Health (NIH), respectively.
Currently, Dr. Lingwood’s lab studies humoral and pro-inflammatory immune responses to vaccines and microbial immune challenges. Through this work, Dr. Lingwood has defined how gene-encoded antigen “pattern” recognition motifs exist within the human antibody/B cell receptor (BCR) repertoire and can serve to naturally re-center antibody recognition upon normally “difficult to see” universal vaccine targets on influenza virus, HIV, SARS-CoV-2 and gram-negative bacteria.
Seminars in Investigative Medicine is a research seminar series at WMed aimed at bringing together the community of investigators both within – and outside — the medical school.